| HOME >> BIOLOGY >> TECHNOLOGY |
Interest Expense (102.9) (25.0)
Other Income, Net 3.7 2.4
Income from Continuing Operations
Before Income Taxes 623.3 202.2
Provision for Income Taxes (78.0) (60.8)
Income from Continuing Operations 545.3 141.4
Income (Loss) from Discontinued
Operations - -
(Loss) Gain on Disposal of
Discontinued Operations (includes
income tax provision of $1.8 and $1.3) (24.0) 2.2
Net Income $521.3 7.3% $143.6 6.8%
Earnings per Share from Continuing
Operations:
Basic $1.29 $.88
Diluted $1.23 $.86
Earnings per Share:
Basic $1.23 $.89
Diluted $1.17 $.88
Weighted Average Shares:
Basic 422.8 160.7
Diluted 444.7 164.9
Reconciliation of Adjusted Operating
Income and Adjusted Operating Margin
GAAP Operating Income (a) $689.4 9.7% $215.1 10.1%
Cost of Revenues Charges (c) 48.0 0.7% 3.3 0.2%
Restructuring and Other Costs, Net (d) 24.5 0.3% 13.6 0.6%
Amortization of Acquisition-related
Intangible Assets 422.9 5.9% 77.6 3.7%
Adjusted Operating Income (b) $1,184.8 16.6% $309.6 14.6%
Reconciliation of Adjusted Net Income
GAAP Net Income (a) $521.3 7.3% $143.6 6.8%
Cost of Revenues Charges (c)
'/>"/>
| SOURCE Thermo Fisher Scientific Inc. Copyright©2007 PR Newswire. All rights reserved |